{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:50:20Z","timestamp":1786117820130,"version":"build-2736575974"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"publisher","award":["R37AI026170"],"award-info":[{"award-number":["R37AI026170"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation centre of excellence","award":["MND210624615487"],"award-info":[{"award-number":["MND210624615487"]}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI114900"],"award-info":[{"award-number":["R01AI114900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI168940"],"award-info":[{"award-number":["R21AI168940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The European & Developing Countries Clinical Trials Partnership (EDCTP) Fellowships","award":["TMA2018SF-2467"],"award-info":[{"award-number":["TMA2018SF-2467"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      There is an urgent need for rapid, affordable diagnostic tools capable of detecting baseline and treatment-emergent resistance among patients with drug-resistant tuberculosis (DR-TB). Reporter mycobacteriophages provide a phenotypic solution enhanced by brighter luminescent reporters compatible with simple readouts. We applied the TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      reporter mycobacteriophage for rapid phenotypic drug susceptibility testing (pDST) on serial\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      isolates from six DR-TB patients, including four with treatment-emergent resistance and two with baseline bedaquiline (BDQ)-resistant subpopulations. Susceptibility to BDQ, pretomanid (PMD), delamanid (DLM), and linezolid (LZD) was assessed by luminescence retention after TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      infection compared to no-drug control, with conventional pDST and whole-genome sequencing as the reference standard. Isolates with baseline and treatment-emergent resistance to BDQ and PMD had a mean relative luminescence unit (RLU) retention of 83.8% (95% CI, 52.1\u2013115.6), while susceptible clinical isolates retained 1.5% mean RLU (95% CI, 0.2\u20132.8). The TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      DST results were consistent with conventional pDST in detecting BDQ and PMD resistance. Three patients with BDQ treatment-emergent resistance had mutations in\n                      <jats:italic toggle=\"yes\">mmpR5<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Rv0678<\/jats:italic>\n                      ), with a range of variant frequencies (12.6%\u201392.3%). One isolate with treatment-emergent DLM\/PMD resistance had mutations in the\n                      <jats:italic toggle=\"yes\">fbiC<\/jats:italic>\n                      gene, with A487fs and S534stop variants at 25.0% and 12.0%, respectively. Sequencing of serial isolates from one patient on a regimen that included LZD identified an emergent mutation in\n                      <jats:italic toggle=\"yes\">rrl<\/jats:italic>\n                      (n.2814G &gt; T, 53.8% frequency); however, the isolate was LZD susceptible by both TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      DST and conventional pDST. TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      reporter mycobacteriophage accurately detected baseline and treatment-emergent resistance to BDQ and PMD compared to conventional pDST. This rapid, phenotypic approach shows promise for accelerating detection of resistance to new and repurposed DR-TB drugs in clinical settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>\n                      Ongoing transmission of drug-resistant tuberculosis (DR-TB), combined with limited access to rapid diagnostics for resistance to key drugs in modern regimens, poses a major challenge to global TB control. We applied TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      reporter mycobacteriophage for rapid phenotypic drug susceptibility testing on\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Mtb<\/jats:italic>\n                      ) clinical isolates with baseline and treatment-emergent resistance to DR-TB drugs (bedaquiline, pretomanid, and delamanid), generating results within 48 h from a positive culture. Our findings provide evidence on the utility of the TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      mycobacteriophage to infect\n                      <jats:italic toggle=\"yes\">Mtb<\/jats:italic>\n                      clinical isolates and distinguish between drug-susceptible and resistant isolates. TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      reporter mycobacteriophage detected emerging resistance to bedaquiline and pretomanid within 48 h from a positive culture, with our results correlating well with conventional phenotypic drug susceptibility and whole-genome sequencing data. These findings support TM4::\n                      <jats:italic toggle=\"yes\">GeNL<\/jats:italic>\n                      reporter mycobacteriophage as a rapid, multiplexed alternative drug-susceptibility test for DR-TB.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.03900-25","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:02:31Z","timestamp":1784120551000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in\n                    <i>Mycobacterium tuberculosis<\/i>\n                    using TM4::\n                    <i>GeNL<\/i>\n                    reporter mycobacteriophages"],"prefix":"10.1128","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4355-5068","authenticated-orcid":false,"given":"Senamile L.","family":"Ngema","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal","place":["Durban, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2201-8028","authenticated-orcid":true,"given":"Saranathan","family":"Rajagopalan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cf8a891","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, Albert Einstein College of Medicine","place":["Bronx, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubeshan","family":"Perumal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal","place":["Durban, South Africa"]},{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pulmonology and Critical Care, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal","place":["Durban, South Africa"]},{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"South African Medical Research Council (SAMRC)\u2013CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal","place":["Durban, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashen","family":"Moodley","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"African Health Research Institute, University of KwaZulu-Natal","place":["Durban, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Guzman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01esghr10","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-8827","authenticated-orcid":false,"given":"Adrie J. C.","family":"Steyn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"African Health Research Institute, University of KwaZulu-Natal","place":["Durban, South Africa"]},{"id":[{"id":"https:\/\/ror.org\/008s83205","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, University of Alabama at Birmingham","place":["Birmingham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William R.","family":"Jacobs","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cf8a891","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, Albert Einstein College of Medicine","place":["Bronx, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kogieleum","family":"Naidoo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal","place":["Durban, South Africa"]},{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"South African Medical Research Council (SAMRC)\u2013CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal","place":["Durban, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"O'Donnell","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01esghr10","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center","place":["New York, USA"]},{"id":[{"id":"https:\/\/ror.org\/01esghr10","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Epidemiology, Columbia University Medical Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-350X","authenticated-orcid":true,"given":"Michelle H.","family":"Larsen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cf8a891","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, Albert Einstein College of Medicine","place":["Bronx, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01107-x"},{"key":"e_1_3_4_3_2","unstructured":"World Health Organization. 2024. Global tuberculosis report 2024. https:\/\/wwwwhoint\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017863"},{"key":"e_1_3_4_5_2","volume-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment.","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019. WHO consolidated guidelines on drug-resistant tuberculosis treatment."},{"key":"e_1_3_4_6_2","volume-title":"The use of bedaquiline in the treatment of multidrug-resistant tuberculosis :: interim policy guidance","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis :: interim policy guidance. WHO, Geneva, Switzerland."},{"key":"e_1_3_4_7_2","unstructured":"World Health Organization. 2016. WHO treatment guidelines for drug-re- sistant tuberculosis."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00010-2015"},{"key":"e_1_3_4_9_2","unstructured":"World Health Organization. 2018. Key changes to treatment of multi- drug- and rifampicin-resistant tuberculosis. Rapid communication. Geneva Switzerland. WHO."},{"key":"e_1_3_4_10_2","unstructured":"World Health Organization. 2022. Key changes to the treatment of drug- resistant tuberculosis. Rapid communication. Geneva Switzerland. WHO."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00180-19"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901814"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad312"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2103049"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1505196"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30031-8"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S408976"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02116-16"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00884-20"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1196-0"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v31i1.4"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.10.004"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S381643"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa136"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06192-11"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03530-14"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00922"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00411-20"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae438"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13010027"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002940"},{"key":"e_1_3_4_32_2","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. 2023. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. 2nd ed","edition":"2"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa755"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008287"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177167"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz074"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03900-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03900-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:42:53Z","timestamp":1786027373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.03900-25"}},"subtitle":[],"editor":[{"given":"Sophia B.","family":"Georghiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,4]]}},"alternative-id":["10.1128\/spectrum.03900-25"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.03900-25","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"2025-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e03900-25"}}